{"id":"https://openalex.org/W2240934769","doi":null,"title":"Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. A review.","display_name":"Preliminary clinical studies with thromboxane synthase inhibitors and thromboxane receptor blockers. A review.","publication_year":1990,"publication_date":"1990-01-01","ids":{"openalex":"https://openalex.org/W2240934769","mag":"2240934769","pmid":"https://pubmed.ncbi.nlm.nih.gov/2136820"},"language":"en","primary_location":{"id":"pmid:2136820","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2136820","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039580874","display_name":"Garrick I. Fiddler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G I Fiddler","raw_affiliation_strings":["Glaxo Group Research Limited, Greenford, Middlesex, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Glaxo Group Research Limited, Greenford, Middlesex, UK","institution_ids":[]}]},{"author_position":"last","author":{"id":null,"display_name":"P Lumley","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P Lumley","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":6.8099,"has_fulltext":false,"cited_by_count":71,"citation_normalized_percentile":{"value":0.9734742,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"81","issue":"1 Suppl","first_page":"I69","last_page":"78; discussion I79"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.6255000233650208,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11064","display_name":"Antiplatelet Therapy and Cardiovascular Diseases","score":0.6255000233650208,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12910","display_name":"Eicosanoids and Hypertension Pharmacology","score":0.1956000030040741,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10678","display_name":"Inflammatory mediators and NSAID effects","score":0.06849999725818634,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/thromboxane-synthase-inhibitor","display_name":"thromboxane synthetase inhibitor","score":0.996999979019165},{"id":"https://openalex.org/keywords/thromboxane-a2","display_name":"thromboxane A2","score":0.9800000190734863},{"id":"https://openalex.org/keywords/platelet-aggregation","display_name":"platelet aggregation","score":0.875},{"id":"https://openalex.org/keywords/unstable-angina","display_name":"unstable angina","score":0.8109999895095825},{"id":"https://openalex.org/keywords/peripheral-vascular-disease","display_name":"peripheral vascular disease","score":0.8970000147819519},{"id":"https://openalex.org/keywords/raynaud-s-phenomenon","display_name":"Raynaud's phenomenon","score":0.9700000286102295},{"id":"https://openalex.org/keywords/pulmonary-hypertension","display_name":"pulmonary hypertension","score":0.925000011920929},{"id":"https://openalex.org/keywords/cerebral-vasospasm","display_name":"cerebral vasospasm","score":0.9670000076293945},{"id":"https://openalex.org/keywords/hepatorenal-syndrome","display_name":"hepatorenal syndrome","score":0.8600000143051147},{"id":"https://openalex.org/keywords/acute-respiratory-distress-syndrome","display_name":"acute respiratory distress syndrome","score":0.9570000171661377},{"id":"https://openalex.org/keywords/cardiopulmonary-bypass","display_name":"cardiopulmonary bypass","score":0.9399999976158142},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.9769999980926514},{"id":"https://openalex.org/keywords/prostaglandin-endoperoxides","display_name":"prostaglandin endoperoxides","score":0.8629999756813049},{"id":"https://openalex.org/keywords/restenosis-after-angioplasty","display_name":"restenosis after angioplasty","score":0.8960000276565552}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8542333245277405},{"id":"https://openalex.org/C173202427","wikidata":"https://www.wikidata.org/wiki/Q408575","display_name":"Thromboxane-A synthase","level":4,"score":0.8402674198150635},{"id":"https://openalex.org/C2781024287","wikidata":"https://www.wikidata.org/wiki/Q774909","display_name":"Thromboxane A2","level":3,"score":0.8259272575378418},{"id":"https://openalex.org/C51603380","wikidata":"https://www.wikidata.org/wiki/Q411978","display_name":"Thromboxane receptor","level":4,"score":0.6231762170791626},{"id":"https://openalex.org/C2776785769","wikidata":"https://www.wikidata.org/wiki/Q412212","display_name":"Thromboxane","level":3,"score":0.6092846393585205},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4549233317375183},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.42276573181152344},{"id":"https://openalex.org/C2778425758","wikidata":"https://www.wikidata.org/wiki/Q180762","display_name":"Angina","level":3,"score":0.41397565603256226},{"id":"https://openalex.org/C89560881","wikidata":"https://www.wikidata.org/wiki/Q101026","display_name":"Platelet","level":2,"score":0.29124006628990173},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.10973688960075378}],"mesh":[{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011982","descriptor_name":"Receptors, Prostaglandin","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D013928","descriptor_name":"Thromboxane A2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D013930","descriptor_name":"Thromboxane-A Synthase","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D017482","descriptor_name":"Receptors, Thromboxane","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2136820","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2136820","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"Journal Article"},{"id":"mag:2240934769","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2136820","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1462178791","https://openalex.org/W1986342394","https://openalex.org/W1984265477","https://openalex.org/W2013216412","https://openalex.org/W2095564746","https://openalex.org/W2047854358","https://openalex.org/W2148543165","https://openalex.org/W1764148511","https://openalex.org/W2335075972","https://openalex.org/W2084655931"],"abstract_inverted_index":{"This":[0],"review":[1],"of":[2,6,88,143,150,158,168,177,194,202,218,237,246,277,282,323,332],"the":[3,18,22,109,144,151,161,181,191,203,216,238,243,329],"clinical":[4,146,163,349],"studies":[5,25,84,354],"thromboxane":[7,12,89,178,219],"synthase":[8,179,220],"inhibitors":[9,281],"(TXSIs)":[10],"and":[11,44,57,62,78,119,241,249,273,328,374],"receptor":[13,240],"blocking":[14],"drugs":[15,169,263],"(TXRBs)":[16],"covers":[17],"years":[19],"1981":[20],"to":[21,136,173,359],"present.":[23],"Clinical":[24],"on":[26,59,104,235],"TXSIs":[27,132,197],"include":[28,67,264,363],"those":[29,36,58,364],"in":[30,37,97,114,126,141,215,225,298,317,334,365],"normal":[31],"volunteers":[32],"as":[33,35],"well":[34],"patients":[38,127,299,306],"with":[39,93,128,165,180,196,300,307,357],"angina,":[40,367],"peripheral":[41,308,369],"vascular":[42,309,370],"disease":[43],"Raynaud's":[45],"syndrome,":[46,52,56],"pulmonary":[47],"hypertension,":[48,373],"cerebral":[49],"vasospasm,":[50],"hepatorenal":[51],"adult":[53],"respiratory":[54],"distress":[55],"cardiopulmonary":[60],"bypass":[61,326],"hemodialysis.":[63],"The":[64,131],"compounds":[65,110,152,279],"studied":[66,133,205],"dazoxiben,":[68],"dazmagrel,":[69],"CGS":[70],"13080,":[71],"CV":[72],"4151,":[73],"OKY":[74,76],"1581,":[75],"046,":[77],"U":[79],"63557A.":[80],"In":[81,107],"volunteers,":[82],"single-dose":[83],"have":[85],"demonstrated":[86],"inhibition":[87,157,221],"A2":[90],"(TXA2)":[91],"formation,":[92],"some":[94,201],"small":[95],"increases":[96],"bleeding":[98],"time":[99],"but":[100,122,303],"no":[101,138],"marked":[102],"effect":[103],"platelet":[105,227,283],"aggregation.":[106,228],"general,":[108],"tested":[111,153],"were":[112,134],"ineffective":[113,297],"both":[115,247],"chronic":[116],"stable":[117,291,301],"angina":[118,121,302],"vasospastic":[120],"caused":[123],"symptomatic":[124],"improvement":[125],"unstable":[129,366],"angina.":[130],"found":[135],"produce":[137],"consistent":[139],"effects":[140,245,331],"any":[142],"other":[145],"conditions.":[147],"Since":[148],"none":[149],"produced":[154],"a":[155,256],"sustained":[156],"TXA2":[159,209,224,239,248,287,333],"synthesis,":[160],"disappointing":[162],"results":[164],"this":[166,361],"class":[167],"may":[170,346],"be":[171,199],"due":[172],"an":[174],"incomplete":[175],"blockade":[176,236],"dosage":[182],"regimens":[183],"used.":[184],"Possible":[185],"alternative":[186],"or":[187,210,288],"additional":[188],"reasons":[189],"for":[190,223,231],"general":[192],"lack":[193],"success":[195],"could":[198],"that":[200,211,344],"diseases":[204],"do":[206],"not":[207],"involve":[208],"accumulating":[212],"prostaglandin":[213,250],"endoperoxides":[214],"presence":[217],"substitute":[222],"causing":[226],"TXRBs":[229,345,358],"rely":[230],"their":[232],"efficacy":[233],"only":[234],"antagonize":[242],"deleterious":[244,330],"H2":[251],"equally,":[252],"so":[253],"they":[254],"represent":[255],"simpler":[257],"pharmacological":[258],"approach":[259],"than":[260,351],"TXSIs.":[261,352],"Such":[262],"AH":[265,294],"23848,":[266],"GR":[267],"32191,":[268],"BM":[269,271,311],"13.177,":[270],"13.505,":[272],"SQ":[274],"28668.":[275],"All":[276],"these":[278,338],"are":[280],"aggregation":[284],"induced":[285],"by":[286,289],"its":[290],"mimetic,":[292],"U-46619.":[293],"23848":[295],"was":[296],"did":[304],"benefit":[305],"disease.":[310,336],"13.177":[312],"has":[313],"also":[314],"proven":[315],"effective":[316],"preventing":[318],"restenosis":[319],"after":[320],"angioplasty,":[321,368],"occlusion":[322],"coronary":[324],"artery":[325],"grafts,":[327],"renal":[335],"From":[337],"preliminary":[339],"studies,":[340],"it":[341],"would":[342],"appear":[343],"offer":[347],"greater":[348],"potential":[350],"Further":[353],"currently":[355],"underway":[356],"resolve":[360],"question":[362],"disease,":[371],"renovascular":[372],"cyclosporine":[375],"nephrotoxicity.":[376]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}